Antibodies.com — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Antibodies.com operates as a global distributor of essential life science research reagents, including antibodies and assay kits. It differentiates itself through a value-driven model, offering products sourced from primary manufacturers at lower prices than industry leaders, supported by PhD-level technical guidance. The company has established logistical hubs in the UK, USA, and Sweden to serve a worldwide customer base, backed by initiatives like travel grants and trial sizes to engage the research community.

Antibodies

Technology Platform

E-commerce and global logistics platform for the aggregation and distribution of third-party manufactured life science research reagents, supported by detailed digital product data and technical guides.

Opportunities

The company is well-positioned to capture market share from larger, more expensive distributors by targeting budget-conscious academic and startup researchers globally.

Growth opportunities exist in expanding the product catalog, enhancing technical support resources, and leveraging community programs to build strong brand loyalty.

Risk Factors

Key risks include dependence on third-party manufacturers for supply, intense competition from well-established reagent giants with greater resources, and the ongoing challenge of building sufficient trust in product quality within the cautious research community.

Competitive Landscape

Antibodies.com competes in the highly fragmented but dominated research reagents market against global leaders like Thermo Fisher Scientific, Abcam, Merck Millipore, and Bio-Techne. Its primary competitive edge is aggressive pricing and customer-centric support, competing against the scale, brand recognition, and vast product portfolios of incumbents.

More companies in Biologics / Biosimilars →More companies in Sweden →